1887

Chapter 18 : Future Technology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Future Technology, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch18-1.gif /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch18-2.gif

Abstract:

This is a very exciting time for the field of clinical diagnostics. In recent years, there has been an explosion in new methodologies and instrumentation to diagnose infection, with a focus on optimization of therapy and antimicrobial stewardship. The result is new technology that improves the diagnosis, characterization, and monitoring of viral infections. These technologies are changing almost every aspect of the laboratory workflow. Most of these new methods achieve marked improvements in turnaround time compared to conventional methods, but this often comes at an increased cost, might be technically demanding, and may require specialized equipment. It is unclear how many of these emerging technologies will rise to widespread, routine clinical use. There are a number of challenges that precede widespread adoption, including regulatory approval and demonstration of adequate analytical performance characteristics. This chapter highlights and summarizes some of the emerging technologies for the diagnosis of viral infections, including digital PCR, next-generation sequencing methods, mass spectrometry, surface plasmon resonance assays, and novel approaches to point-of-care diagnostics. The strengths and limitations of each methodology, as well as potential clinical diagnostic applications, will be described.

Citation: Tekippe E, Burnham C. 2016. Future Technology, p 243-253. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch18
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555819156.ch18
1. Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ, Bonomo RA, Carroll KC, Ferraro MJ, Hirschhorn LR, Joseph WP, Karchmer T, MacIntyre AT, Reller LB, Jackson AF Infectious Diseases Society of America (IDSA). 2013. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis 57(Suppl 3):S139S170.[PubMed]
2. Zumla A, Al-Tawfiq JA, Enne VI, Kidd M, Drosten C, Breuer J, Muller MA, Hui D, Maeurer M, Bates M, Mwaba P, Al-Hakeem R, Gray G, Gautret P, Al-Rabeeah AA, Memish ZA, Gant V. 2014. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects. Lancet Infect Dis 14:11231135.[PubMed]
3. Boonham N, Kreuze J, Winter S, van der Vlugt R, Bergervoet J, Tomlinson J, Mumford R. 2014. Methods in virus diagnostics: from ELISA to next generation sequencing. Virus Res 186:2031.[PubMed]
4. Liu L, Li Y, Li S, Hu N, He Y, Pong R, Lin D, Lu L, Law M. 2012. Comparison of next-generation sequencing systems. J Biomed Biotechnol 2012:251364.[PubMed]
5. Buchan BW, Ledeboer NA. 2014. Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev 27:783822.[PubMed]
6. Rusk N. 2015. MinION takes center stage. Nat Methods 12:1213.[PubMed]
7. Loman NJ, Quinlan AR. 2014. Poretools: a toolkit for analyzing nanopore sequence data. Bioinformatics 30:33993401.[PubMed]
8. Mikheyev AS, Tin MM. 2014. A first look at the Oxford Nanopore MinION sequencer. Mol Ecol Resour 14:10971102.[PubMed]
9. Watson M, Thomson M, Risse J, Talbot R, Santoyo-Lopez J, Gharbi K, Blaxter M. 2015. poRe: an R package for the visualization and analysis of nanopore sequencing data. Bioinformatics 31:114115.[PubMed]
10. Stephenson J. 2015. Genomic technologies speed pathogen detection. JAMA 314:212214.[PubMed]
11. Wylie KM, Weinstock GM, Storch GA. 2012. Emerging view of the human virome. Transl Res 160:283290.[PubMed]
12. Wylie KM, Weinstock GM, Storch GA. 2013. Virome genomics: a tool for defining the human virome. Curr Opin Microbiol 16:479484.[PubMed]
13. Yim D, Curtis N, Cheung M, Burgner D. 2013. Update on Kawasaki disease: epidemiology, aetiology and pathogenesis. J Paediatr Child Health 49:704708.[PubMed]
14. Owens GP, Gilden D, Burgoon MP, Yu X, Bennett JL. 2011. Viruses and multiple sclerosis. The Neuroscientist: a review journal bringing neurobiology, neurology and psychiatry 17:659676.
15. Tselis A. 2011. Evidence for viral etiology of multiple sclerosis. Semin Neurol 31:307316.[PubMed]
16. Voumvourakis KI, Kitsos DK, Tsiodras S, Petrikkos G, Stamboulis E. 2010. Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clin Proc 85:10231030.[PubMed]
17. Saglam O, Samayoa E, Somasekar S, Naccache S, Iwasaki A, Chiu CY. 2015. No viral association found in a set of differentiated vulvar intraepithelial neoplasia cases by human papillomavirus and pan-viral microarray testing. PLoS One 10:e0125292.[PubMed]
18. Baker M. 2012. Digital PCR hits its stride. Nat Methods 9:541544.
19. Hall Sedlak R, Jerome KR. 2014. The potential advantages of digital PCR for clinical virology diagnostics. Expert Rev Mol Diagn 14:501507.[PubMed]
20. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina CA, Woelk CH, Richman DD. 2013. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One 8:e55943.[PubMed]
21. Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, Bosch RJ, Lai J, Chioma S, Emad F, Abdel-Mohsen M, Hoh R, Hecht F, Hunt P, Somsouk M, Wong J, Johnston R, Siliciano RF, Richman DD, O'Doherty U, Palmer S, Deeks SG, Siliciano JD. 2013. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog 9:e1003174.[PubMed]
22. Sedlak RH, Cook L, Cheng A, Magaret A, Jerome KR. 2014. Clinical utility of droplet digital PCR for human cytomegalovirus. J Clin Microbiol 52:28442848.[PubMed]
23. Hayden RT, Gu Z, Ingersoll J, Abdul-Ali D, Shi L, Pounds S, Caliendo AM. 2013. Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus. J Clin Microbiol 51:540546.[PubMed]
24. Roberts CH, Last A, Molina-Gonzalez S, Cassama E, Butcher R, Nabicassa M, McCarthy E, Burr SE, Mabey DC, Bailey RL, Holland MJ. 2013. Development and evaluation of a next-generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections. J Clin Microbiol 51:21952203.[PubMed]
25. Sedlak RH, Cook L, Huang ML, Magaret A, Zerr DM, Boeckh M, Jerome KR. 2014. Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin Chem 60:765772.[PubMed]
26. Boizeau L, Laperche S, Désiré N, Jourdain C, Thibault V, Servant-Delmas A. 2014. Could droplet digital PCR be used instead of real-time PCR for quantitative detection of the hepatitis B virus genome in plasma? J Clin Microbiol 52:34973498.[PubMed]
27. Dong L, Meng Y, Sui Z, Wang J, Wu L, Fu B. 2015. Comparison of four digital PCR platforms for accurate quantification of DNA copy number of a certified plasmid DNA reference material. Sci Rep 5:13174.[PubMed]
28. Deyde VM, Sampath R, Gubareva LV. 2011. RT-PCR/electrospray ionization mass spectrometry approach in detection and characterization of influenza viruses. Expert Rev Mol Diagn 11:4152.[PubMed]
29. Metzgar D, Baynes D, Myers CA, Kammerer P, Unabia M, Faix DJ, Blair PJ. 2010. Initial identification and characterization of an emerging zoonotic influenza virus prior to pandemic spread. J Clin Microbiol 48:42284234.[PubMed]
30. Deyde VM, Sampath R, Garten RJ, Blair PJ, Myers CA, Massire C, Matthews H, Svoboda P, Reed MS, Pohl J, Klimov AI, Gubareva LV. 2010. Genomic signature-based identification of influenza A viruses using RT-PCR/electro-spray ionization mass spectrometry (ESI-MS) technology. PLoS One 5:e13293.[PubMed]
31. Zhang C, Xiao Y, Du J, Ren L, Wang J, Peng J, Jin Q. 2015. Application of multiplex PCR couple with MALDI-TOF analysis for simultaneous detection of 21 common respiratory viruses. J Clin Microbiol.
32. Blyn LB, Hall TA, Libby B, Ranken R, Sampath R, Rudnick K, Moradi E, Desai A, Metzgar D, Russell KL, Freed NE, Balansay M, Broderick MP, Osuna MA, Hofstadler SA, Ecker DJ. 2008. Rapid detection and molecular serotyping of adenovirus by use of PCR followed by electrospray ionization mass spectrometry. J Clin Microbiol 46:644651.[PubMed]
33. Sampath R, Hofstadler SA, Blyn LB, Eshoo MW, Hall TA, Massire C, Levene HM, Hannis JC, Harrell PM, Neuman B, Buchmeier MJ, Jiang Y, Ranken R, Drader JJ, Samant V, Griffey RH, McNeil JA, Crooke ST, Ecker DJ. 2005. Rapid identification of emerging pathogens: coronavirus. Emerg Infect Dis 11:373379.[PubMed]
34. Chen KF, Blyn L, Rothman RE, Ramachandran P, Valsamakis A, Ecker D, Sampath R, Gaydos CA. 2011. Reverse transcription polymerase chain reaction and electrospray ionization mass spectrometry for identifying acute viral upper respiratory tract infections. Diagn Microbiol Infect Dis 69:179186.[PubMed]
35. Ecker DJ, Sampath R, Blyn LB, Eshoo MW, Ivy C, Ecker JA, Libby B, Samant V, Sannes-Lowery KA, Melton RE, Russell K, Freed N, Barrozo C, Wu J, Rudnick K, Desai A, Moradi E, Knize DJ, Robbins DW, Hannis JC, Harrell PM, Massire C, Hall TA, Jiang Y, Ranken R, Drader JJ, White N, McNeil JA, Crooke ST, Hofstadler SA. 2005. Rapid identification and strain-typing of respiratory pathogens for epidemic surveillance. Proc Natl Acad Sci USA 102:80128017.[PubMed]
36. Grant RJ, Baldwin CD, Nalca A, Zoll S, Blyn LB, Eshoo MW, Matthews H, Sampath R, Whitehouse CA. 2010. Application of the Ibis-T5000 pan-Orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox virus. Am J Trop Med Hyg 82:318323.[PubMed]
37. Eshoo MW, Whitehouse CA, Zoll ST, Massire C, Pennella TT, Blyn LB, Sampath R, Hall TA, Ecker JA, Desai A, Wasieloski LP, Li F, Turell MJ, Schink A, Rudnick K, Otero G, Weaver SC, Ludwig GV, Hofstadler SA, Ecker DJ. 2007. Direct broad-range detection of alphaviruses in mosquito extracts. Virology 368:286295.[PubMed]
38. Grant-Klein RJ, Baldwin CD, Turell MJ, Rossi CA, Li F, Lovari R, Crowder CD, Matthews HE, Rounds MA, Eshoo MW, Blyn LB, Ecker DJ, Sampath R, Whitehouse CA. 2010. Rapid identification of vector-borne flaviviruses by mass spectrometry. Mol Cell Probes 24:219228.[PubMed]
39. Ecker DJ, Sampath R, Massire C, Blyn LB, Hall TA, Eshoo MW, Hofstadler SA. 2008. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 6:553558.[PubMed]
40. Wolk DM, Kaleta EJ, Wysocki VH. 2012. PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn 14:295304.[PubMed]
41. Emonet S, Shah HN, Cherkaoui A, Schrenzel J. 2010. Application and use of various mass spectrometry methods in clinical microbiology. Clin Microbiol Infec 16:16041613.
42. Wang D, Coscoy L, Zylberberg M, Avila PC, Boushey HA, Ganem D, DeRisi JL. 2002. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci USA 99:1568715692.[PubMed]
43. Chen EC, Miller SA, DeRisi JL, Chiu CY. 2011. Using a pan-viral microarray assay (Virochip) to screen clinical samples for viral pathogens. J Vis Exp (50):2536.[PubMed]
44. Palacios G, Quan PL, Jabado OJ, Conlan S, Hirschberg DL, Liu Y, Zhai J, Renwick N, Hui J, Hegyi H, Grolla A, Strong JE, Towner JS, Geisbert TW, Jahrling PB, Büchen-Osmond C, Ellerbrok H, Sanchez-Seco MP, Lussier Y, Formenty P, Nichol MS, Feldmann H, Briese T, Lipkin WI. 2007. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 13:7381.[PubMed]
45. Gardner SN, Jaing CJ, McLoughlin KS, Slezak TR. 2010. A microbial detection array (MDA) for viral and bacterial detection. BMC Genomics 11:668.[PubMed]
46. Nicholson TL, Kukielka D, Vincent AL, Brockmeier SL, Miller LC, Faaberg KS. 2011. Utility of a panviral microarray for detection of swine respiratory viruses in clinical samples. J Clin Microbiol 49:15421548.[PubMed]
47. Kistler A, Avila PC, Rouskin S, Wang D, Ward T, Yagi S, Schnurr D, Ganem D, DeRisi JL, Boushey HA. 2007. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 196:817825.[PubMed]
48. Chiu CY, Urisman A, Greenhow TL, Rouskin S, Yagi S, Schnurr D, Wright C, Drew WL, Wang D, Weintrub PS, Derisi JL, Ganem D. 2008. Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children. J Pediatr 153:7683.[PubMed]
49. Chiu CY, Rouskin S, Koshy A, Urisman A, Fischer K, Yagi S, Schnurr D, Eckburg PB, Tompkins LS, Blackburn BG, Merker JD, Patterson BK, Ganem D, DeRisi JL. 2006. Microarray detection of human parainfluenzavirus 4 infection associated with respiratory failure in an immunocompetent adult. Clin Infect Dis 43:e71e76.[PubMed]
50. Chiu CY, Alizadeh AA, Rouskin S, Merker JD, Yeh E, Yagi S, Schnurr D, Patterson BK, Ganem D, DeRisi JL. 2007. Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarray. J Clin Microbiol 45:23402343.[PubMed]
51. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Günther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:13941399.[PubMed]
52. Greninger AL, Chen EC, Sittler T, Scheinerman A, Roubinian N, Yu G, Kim E, Pillai DR, Guyard C, Mazzulli T, Isa P, Arias CF, Hackett J, Schochetman G, Miller S, Tang P, Chiu CY. 2010. A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS One 5:e13381.[PubMed]
53. Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung'u T, Ruxrungtham K, Sanchez J, Brander C, Chung RT, O'Connor KC, Walker B, Larman HB, Elledge SJ. 2015. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science 348:aaa0698.[PubMed]
54. Safina G. 2012. Application of surface plasmon resonance for the detection of carbohydrates, glycoconjugates, and measurement of the carbohydrate-specific interactions: a comparison with conventional analytical techniques. A critical review. Anal Chim Acta 712:929.[PubMed]
55. Suenaga E, Mizuno H, Kumar PK. 2012. Influenza virus surveillance using surface plasmon resonance. Virulence 3:464470.[PubMed]
56. Suenaga E, Mizuno H, Penmetcha KK. 2012. Monitoring influenza hemagglutinin and glycan interactions using surface plasmon resonance. Biosens Bioelectron 32:195201.[PubMed]
57. Wang HN, Fales AM, Zaas AK, Woods CW, Burke T, Ginsburg GS, Vo-Dinh T. 2013. Surface-enhanced Raman scattering molecular sentinel nanoprobes for viral infection diagnostics. Anal Chim Acta 786:153158.[PubMed]
58. Hoang V, Tripp RA, Rota P, Dluhy RA. 2010. Identification of individual genotypes of measles virus using surface enhanced Raman spectroscopy. Analyst (Lond) 135:31033109.[PubMed]
59. Su LC, Tian YC, Chang YF, Chou C, Lai CS. 2014. Rapid detection of urinary polyomavirus BK by heterodyne-based surface plasmon resonance biosensor. J Biomed Opt 19:011013.[PubMed]
60. Rusnati M, Chiodelli P, Bugatti A, Urbinati C. 2015. Bridging the past and the future of virology: surface plasmon resonance as a powerful tool to investigate virus/host interactions. Crit Rev Microbiol 41:238260.[PubMed]
61. Petrozzino JJ, Smith C, Atkinson MJ. 2010. Rapid diagnostic testing for seasonal influenza: an evidence-based review and comparison with unaided clinical diagnosis. J Emerg Med 39:476490.
62. Centers for Disease Control and Prevention. 2012. Evaluation of 11 commercially available rapid influenza diagnostic tests—United States, 2011–2012. MMWR Morb Mortal Wkly Rep 61:873876.[PubMed]
63. Gao F, Loring C, Laviolette M, Bolton D, Daly ER, Bean C. 2012. Detection of 2009 pandemic influenza A(H1N1) virus Infection in different age groups by using rapid influenza diagnostic tests. Influenza Other Respi Viruses 6:e30e34.[PubMed]
64. Kumar S, Henrickson KJ. 2012. Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev 25:344361.[PubMed]
65. Cheng VC, To KK, Tse H, Hung IF, Yuen KY. 2012. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev 25:223263.[PubMed]
66. Cheng PK, Wong KK, Mak GC, Wong AH, Ng AY, Chow SY, Lam RK, Lau CS, Ng KC, Lim W. 2010. Performance of laboratory diagnostics for the detection of influenza A(H1N1)v virus as correlated with the time after symptom onset and viral load. J Clin Virol 47:182185.
67. August 2014. Sophia Influenza A+B FIA, Quidel Corp. Pagckage Insert In 1219103EN01 (ed.).
68. Lewandrowski K, Tamerius J, Menegus M, Olivo PD, Lollar R, Lee-Lewandrowski E. 2013. Detection of influenza A and B viruses with the Sofia analyzer: a novel, rapid immunofluorescence-based in vitro diagnostic device. Am J Clin Pathol 139:684689.[PubMed]
69. Leonardi GP, Wilson AM, Zuretti AR. 2013. Comparison of conventional lateral-flow assays and a new fluorescent immunoassay to detect influenza viruses. J Virol Methods 189:379382.[PubMed]
70. Lee CK, Cho CH, Woo MK, Nyeck AE, Lim CS, Kim WJ. 2012. Evaluation of Sofia fluorescent immunoassay analyzer for influenza A/B virus. J Clin Virol 55:239243.
71. April 2012. BD Veritor System for Rapid Detection of Flu A+B. In Company BDa (ed.), Package Insert 8087667(03).
72. Peters TR, Blakeney E, Vannoy L, Poehling KA. 2013. Evaluation of the limit of detection of the BD Veritor™ system flu A+B test and two rapid influenza detection tests for influenza virus. Diagn Microbiol Infect Dis 75:200202.[PubMed]
73. Nam MH, Jang JW, Lee JH, Cho CH, Lim CS, Kim WJ. 2014. Clinical performance evaluation of the BD Veritor System Flu A+B assay. J Virol Methods 204:8690.[PubMed]
74. Hassan F, Nguyen A, Formanek A, Bell JJ, Selvarangan R. 2014. Comparison of the BD Veritor System for Flu A+B with the Alere BinaxNOW influenza A&B card for detection of influenza A and B viruses in respiratory specimens from pediatric patients. J Clin Microbiol 52:906910.[PubMed]
75. Dunn J, Obuekwe J, Baun T, Rogers J, Patel T, Snow L. 2014. Prompt detection of influenza A and B viruses using the BD Verito System Flu A+B, Quidel Sofia Influenza A+B FIA, and Alere BinaxNOW Influenza A&B compared to real-time reverse transcription-polymerase chain reaction (RT-PCR). Diagn Microbiol Infect Dis 79:1013.[PubMed]
76. Nie S, Roth RB, Stiles J, Mikhlina A, Lu X, Tang YW, Babady NE. 2014. Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol 52:33393344.[PubMed]
77. Bell J, Bonner A, Cohen DM, Birkhahn R, Yogev R, Triner W, Cohen J, Palavecino E, Selvarangan R. 2014. Multicenter clinical evaluation of the novel Alere i Influenza A&B isothermal nucleic acid amplification test. J Clin Virol 61:8186.
78. Chen L, Tian Y, Chen S, Liesenfeld O. 2015. Performance of the Cobas influenza A/B assay for rapid PCR-based detection of influenza compared to Prodesse ProFlu+ and viral culture. Eur J Microbiol Immunol (Bp) 5:236245.[PubMed]
79. Binnicker MJ, Espy MJ, Irish CL, Vetter EA. 2015. Direct detection of influenza A and B viruses in less than 20 minutes using a commercially available rapid PCR assay. J Clin Microbiol 53:23532354.[PubMed]
80. Drain PK, Garrett NJ. 2015. The arrival of a true point-of-care molecular assay-ready for global implementation? Lancet Glob Health 3:e663e664.[PubMed]
81. Svensson MJ, Lind I, Wirgart BZ, Östlund MR, Albert J. 2014. Performance of the Simplexa Flu A/B & RSV Direct Kit on respiratory samples collected in saline solution. Scand J Infect Dis 46:825831.[PubMed]
82. Hindiyeh M, Kolet L, Meningher T, Weil M, Mendelson E, Mandelboim M. 2013. Evaluation of Simplexa Flu A/B & RSV for direct detection of influenza viruses (A and B) and respiratory syncytial virus in patient clinical samples. J Clin Microbiol 51:24212424.[PubMed]
83. Selvaraju SB, Bambach AV, Leber AL, Patru MM, Patel A, Menegus MA. 2014. Comparison of the Simplexa Flu A/B & RSV kit (nucleic acid extraction-dependent assay) and the Prodessa ProFlu+ assay for detecting influenza and respiratory syncytial viruses. Diagn Microbiol Infect Dis 80:5052.[PubMed]
84. Woodberry MW, Shankar R, Cent A, Jerome KR, Kuypers J. 2013. Comparison of the Simplexa FluA/B & RSV direct assay and laboratory-developed real-time PCR assays for detection of respiratory virus. J Clin Microbiol 51:38833885.[PubMed]
85. Selvaraju SB, Tierney D, Leber AL, Patel A, Earley AK, Jaiswal D, Menegus MA. 2014. Influenza and respiratory syncytial virus detection in clinical specimens without nucleic acid extraction using FOCUS direct disc assay is substantially equivalent to the traditional methods and the FOCUS nucleic acid extraction-dependent RT-PCR assay. Diagn Microbiol Infect Dis 78:232236.[PubMed]
86. Hardie A, Mackenzie L, Guerendiain D, Templeton K. 2015. Evaluation of Enigma MiniLabTM Influenza A/B RSV assay designed for rapid testing and point of care diagnosis. J Clin Virol 70:S68.
87. Douthwaite ST, Walker C, Adams EJ, Mak C, Vecino Ortiz A, Martinez-Alier N, Goldenberg SD. 2016. Performance of a novel point-of-care molecular assay for detection of influenza A and B viruses and respiratory syncytial virus (Enigma MiniLab) in children with acute respiratory infection. J Clin Microbiol 54:212215.[PubMed]
88. Kania D, Truong TN, Montoya A, Nagot N, Van de Perre P, Tuaillon E. 2015. Performances of fourth generation HIV antigen/antibody assays on filter paper for detection of early HIV infections. J Clin Virol 62:9297.
89. Pilcher CD, Louie B, Facente S, Keating S, Hackett J Jr, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW. 2013. Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One 8:e80629.[PubMed]
90. Jani IV, Meggi B, Mabunda N, Vubil A, Sitoe NE, Tobaiwa O, Quevedo JI, Lehe JD, Loquiha O, Vojnov L, Peter TF. 2014. Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test. J Acquir Immune Defic Syndr 67:e1e4.[PubMed]
91. Tang S, Zhao J, Wang A, Viswanath R, Harma H, Little RF, Yarchoan R, Stramer SL, Nyambi PN, Lee S, Wood O, Wong EY, Wang X, Hewlett IK. 2010. Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection. Clin Vaccine Immunol 17:12441251.[PubMed]
92. Liu J, Du B, Zhang P, Haleyurgirisetty M, Zhao J, Ragupathy V, Lee S, DeVoe DL, Hewlett IK. 2014. Development of a microchip Europium nanoparticle immunoassay for sensitive point-of-care HIV detection. Biosens Bioelectron 61:177183.[PubMed]
93. Parry CM, Parkin N, Diallo K, Mwebaza S, Batamwita R, DeVos J, Bbosa N, Lyagoba F, Magambo B, Jordan MR, Downing R, Zhang G, Kaleebu P, Yang C, Bertagnolio S. 2014. Field study of dried blood spot specimens for HIV-1 drug resistance genotyping. J Clin Microbiol 52:28682875.[PubMed]
94. Vogel G. 2014. Infectious Diseases. Testing new Ebola tests. Science 345:15491550.[PubMed]
95. Walker NF, Brown CS, Youkee D, Baker P, Williams N, Kalawa A, Russell K, Samba AF, Bentley N, Koroma F, King MB, Parker BE, Thompson M, Boyles T, Healey B, Kargbo B, Bash-Taqi D, Simpson AJ, Kamara A, Kamara TB, Lado M, Johnson O, Brooks T. 2015. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20.

Tables

Generic image for table
TABLE 1

Summary of diagnostic assays for Ebola virus

Citation: Tekippe E, Burnham C. 2016. Future Technology, p 243-253. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch18

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error